Institutional Ownership
Q/C Technologies Inc
CUSIP 62856X300COMQCLSQ1 2026
13D / 13G Filings
1
Schedule 13D/13G on record
Beneficial Filers
1
Distinct reporting persons
Largest Stake
74.0%
Max % of class reported
Institutional Holders
16
13F filers (latest quarter)
Beneficial Owners — Schedule 13D / 13G
1 filings · latest Nov 18, 2025
| # | Filed | Reporting Person | Form | % of Class | Shares | Filing |
|---|---|---|---|---|---|---|
| 1 | Nov 18, 2025 | Pharmacyte Biotech, Inc. | 13D/A | 74.0% | — | SEC |
Top Institutional Holders (13F)
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Quinn Opportunity Partners LLC | 211.4K | $729.3K |
| 2 | Jane Street Group, LLC | 126.2K | $435.3K |
| 3 | Ubs Group AG | 78.0K | $269.1K |
| 4 | Adar1 Capital Management, LLC | 50.0K | $172.5K |
| 5 | Geode Capital Management, LLC | 47.4K | $163.5K |
| 6 | Dimensional Fund Advisors LP | 19.1K | $65.8K |
| 7 | State Street Corp | 12.9K | $44.5K |
| 8 | Sunbelt Securities, Inc. | 1.8K | $6.0K |
| 9 | Tower Research Capital LLC (Trc) | 1.6K | $5.5K |
| 10 | Bnp Paribas Financial Markets | 300 | $1.0K |